Haemonetics Corporation (NYSE:HAE) Expands Margins, Signals Near-Term Operational Upside
![]() |
Operational margin expansion and a targeted vascular-closure acquisition shift momentum toward constructive near-term performance. Balance-sheet liquidity and free cash generation underpin a valuation the WMDST team classifies as under-valued. |










